ZPL389 is a new once-daily oral H4 receptor antagonist that is currently being studied for the treatment of atopic dermatitis, commonly referred as eczema. Novartis recently purchased the rights to this medication from Ziarco, a private company focused on the development of treatments in dermatology. There currently is no specific oral medication used for the […]
AllergyLosAngeles.com named Top Allergy Blog
We are proud to announce that our blog, was named one of the top 10 allergy blogs in the world by feedspot.com Top Allergy Blogs The list was based on quality of articles, quality and consistency of posts, social media influence and Feedspot’s editorial team and expert review. Being picked as a top allergy blog […]
New Peanut Guidelines
New peanut guidelines have been officially introduced by the National Institute of Allergy and Infectious Diseases in response to the earlier studies we have discussed from the LEAP trials. Peanut Allergy Prevention Peanut allergy is a growing public health problem. In the United States, peanut allergy prevalence is approximately 2% among children. Peanut allergy is […]
Alternative Agents for Refractory Chronic Urticaria Patients
Chronic urticaria is defined for a period of at least 6 weeks with hives. Patients with chronic urticaria who fail high-dose antihistamines should be referred to an allergy specialist to help manage their condition. We have previously spoke about the stepwise approach to chronic idiopathic/spontaneous urticaria. Stepwise approach to Chronic Urticaria (Chronic Hives) Patients with […]
Auvi-Q to return to market
Auvi-Q is set to return to the market February 14, 2017. Auvi-Q was withdrawn off the market in the past because improper dosing and later it was sold to Kaleo. Auvi-Q Recall Many were wondering if Auvi-Q would ever return to the market again. Many patients liked the small packaging and the fact that it […]
Eucrisa (crisaborole) New Eczema Medication gets FDA Approval
Eucrisa (crisaborole) recently won FDA approval for eczema (atopic dermatitis). This would be the first non-steroidal skin therapy for eczema in 15 years, since Elidel and Protopic were approved. Pfizer recently bought the rights to Eucrisa (crisaborole) back in May when it acquired its developer, Anacor, for 5.2 billion dollars. There were 2 trials, consisting […]
Does Xolair Work for Eczema?
Does Xolair work for eczema? Is a question that has been asked by many atopic dermatitis sufferers since the drug came out. Omalizumab targets IgE and many patients with eczema have extremely high levels of IgE. The only problem is that it approved for patients who have asthma whose IgE go up to 700 IU/ml, […]
Sublingual Dust Mite Immunotherapy
Sublingual dust mite immunotherapy tablets are currently being developed by Merck. House dust mite is the most common cause of perennial allergic rhinitis worldwide. Symptoms of house dust mite allergies can be treated with medications or allergy immunotherapy, currently available in the shot form or sublingual drops. The sublingual drops have shown good efficacy is […]
HBO’s ‘The Night Of’ and Eczema
For those of you who watched HBO’s drama ‘The Night Of’, you would have seen one of the many characters, John Stone played by John Turturro suffer from eczema (atopic dermatitis). If you have not seen this mini-series yet, do not worry this blog post contains no spoilers central to the main plot line. As […]
Does High Alcohol Consumption Cause Allergies?
Does high alcohol consumption cause allergies? That is question many have wondered as patients with alcohol intake have complained about allergy symptoms. To measure this, scientists measured the IgE levels in patients. IgE is thought to play an important role in allergic diseases, such as asthma, allergic rhinitis and allergic eczema. Thus high total IgE […]









